ArticleCell proliferation2025

Terazosin, a repurposed GPR119 agonist, ameliorates mitophagy and β-cell function in NAFPD by inhibiting MST1-Foxo3a signalling pathway.

Chenglei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.